CDC investor presentation and guidance update
| Stock | Infratil Ltd (IFT.ASX) |
|---|---|
| Release Time | 26 Mar 2026, 7:31 a.m. |
| Price Sensitive | Yes |
CDC investor presentation and guidance update
- Data centre demand thematics remain very strong
- CDC's operational capacity to significantly boost with new data centres
- Increased FY27 EBITDAF guidance to A$680-720 million
Infratil is holding a briefing for analysts and institutional investors in Sydney featuring a presentation from Australasian data centre operator CDC. Infratil CEO Jason Boyes said data centre demand thematics remain very strong, and Infratil's focus is on supporting CDC to deliver more capacity to meet the growing demand for data centre space across Australasia. Infratil, along with CDC's other major shareholders, recently provided A$500 million in equity funding to support the acceleration of CDC's construction programme. Today's event includes a site tour to CDC's Eastern Creek campus, where two additional data centres are nearing operational status and will significantly boost CDC's operational capacity. Infratil had previously guided that CDC's FY25 EBITDAF would double to approximately A$660 million in FY27. Higher formal FY27 EBITDAF guidance of A$680 million to A$720 million is now provided based on the updated outlook for delivery of existing contracted capacity and the expectation for continued strong demand. FY26 EBITDAF is expected to be at the lower end of the current guidance range of A$390 million to A$400 million, reflecting the timing of existing contracted capacity that has been weighted toward the back end of FY26. CDC CEO Greg Boorer said recent geopolitical developments have highlighted Australasia's secure position and competitive differentiation as a strategic location for data centres, and CDC is having more conversations with strategic customers about their increased capacity needs and continuing to build new intelligence generation capacity as fast as possible to meet that increasing demand.
FY27 EBITDAF guidance set at A$680-720 million. FY26 EBITDAF expected at the lower end of the current guidance range of A$390 million to A$400 million.
CDC has the largest pipeline of capacity within Australasia with 18 operational sites and another 5 under construction. CDC is having more conversations with strategic customers about their increased capacity needs and continuing to build new intelligence generation capacity as fast as possible to meet that increasing demand.